ProQR Therapeutics N.V. buy StockNews.com
Start price
11.11.23
/
50%
€1.25
Target price
11.11.24
-
Performance (%)
43.84%
Price
26.08.24
€1.84
Summary
This prediction is currently active. With a performance of 43.84% the BUY prediction by StockNews_com is a big success. This prediction currently runs until 11.11.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
ProQR Therapeutics N.V. | -4.013% | -4.013% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by StockNews_com for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by StockNews_com for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.56
22.06.24
22.06.24
-
22.06.25
22.06.25
15.48%
26.08.24
26.08.24
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.81
11.05.24
11.05.24
-
11.05.25
11.05.25
-0.39%
26.08.24
26.08.24
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.81
12.03.24
12.03.24
-
12.03.25
12.03.25
-4.19%
26.08.24
26.08.24